A tentative ceasefire in the US-Iran conflict sparked a powerful rally across global markets, propelling the iShares MSCI World ETF (URTH) to a new 52-week high of $195.79 on Friday, April 17. The gain of 1.25% was fueled by reports of the truce and the reopening of the Strait of Hormuz to commercial traffic, which sent oil prices plunging over ten percent and eased near-term inflation fears.
This geopolitical relief dovetailed with a robust start to the Q1 2026 earnings season, creating a dual-engine boost for the fund. Major banking constituents reported stellar results: Goldman Sachs saw annual profit rise 19%, Morgan Stanley’s surged 29%, and JPMorgan Chase posted record trading revenue of $11.6 billion. Financial stocks are among the heaviest weightings in the MSCI World index, making their strength a direct catalyst for the ETF.
Yet, the fund’s impressive run now faces a critical test from the very companies that powered it. Extreme sector concentration presents a structural risk, with technology stocks accounting for over 26% of the portfolio. Just three giants—Nvidia, Apple, and Microsoft—comprise a combined 13.6%. Microsoft, with a 3.44% fund weighting, is set to report quarterly results on April 29. While TD Cowen maintains a buy rating, it recently trimmed its price target to $540, citing GPU infrastructure capacity constraints. Microsoft’s performance, following a prior quarter with 17% revenue growth and a 39% surge in Azure, will be scrutinized for its impact on the entire ETF.
The week ahead holds another key event. On Tuesday, April 22, index provider MSCI Inc. releases its own Q1 2026 figures, with analysts forecasting earnings of $4.37 per share on revenue of approximately $835 million. More significantly, the market is preparing for MSCI’s scheduled index review in May, which will introduce a new three-category free-float classification system. Analysts anticipate this reform will trigger larger portfolio shifts than the previous review, which saw 18 additions and 27 deletions, potentially altering the weightings of mega-caps like Nvidia and Apple.
Should investors sell immediately? Or is it worth buying MSCI World ETF?
Beyond earnings and index mechanics, other pressures loom. The US administration has announced punitive tariffs on imported pharmaceuticals, set for late July 2026, with rates up to 100% for manufacturers without US pricing agreements. This threatens margins for the healthcare sector, which represents 9.45% of URTH’s holdings. On the cost front, competitor Invesco has slashed its ETF fee to 0.05%, putting pressure on the iShares product’s total expense ratio of 0.24%. BlackRock defends its fee by pointing to a narrow tracking difference of just 0.02%, an argument that appears to resonate with large institutions like the Royal Bank of Canada, which recently increased its position by 17.5% to roughly two million shares.
The current valuation premium for US tech has notably compressed, with the sector’s forward P/E at its lowest level since mid-2020. Analysts project earnings growth of 43% for the sector in 2026, up from 26% the prior year. For income-focused investors, the next key date is the ex-dividend day on June 15, 2026, following a year of dividend growth exceeding 20%.
With $8 billion in assets under management and 1,311 individual holdings, the iShares MSCI World ETF sits at a crossroads. Its recent record high, built on geopolitical calm and stellar bank profits, must now withstand the verdict of tech earnings and navigate imminent structural shifts in its underlying index.
Ad
MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from April 19 delivers the answer:
The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 19.
MSCI World ETF: Buy or sell? Read more here...
